Valuation: FDC Limited

Market Cap 5.81TCr 61Cr 54Cr 50Cr 46Cr 87Cr 88Cr 605.99Cr 237.6Cr 3.03TCr 229.65Cr 224.76Cr 9.66TCr P/E 2025
24.1x
P/E 2026 18.6x
Enterprise Value 5.3TCr 56Cr 50Cr 46Cr 42Cr 79Cr 80Cr 553.19Cr 216.89Cr 2.77TCr 209.64Cr 205.17Cr 8.82TCr EV / Sales 2025
2.8x
EV / Sales 2026 2.18x
Free-Float
30.06%
Yield 2025
1.27%
Yield 2026 1.56%
1 day+1.55%
1 week+8.06%
Current month+4.99%
1 month+1.64%
3 months-15.01%
6 months-0.54%
Current year-15.73%
1 week 327.05
Extreme 327.05
364.2
1 month 321.5
Extreme 321.5
365
Current year 314.75
Extreme 314.75
442
1 year 314.75
Extreme 314.75
473.3
3 years 314.75
Extreme 314.75
659
5 years 229.15
Extreme 229.15
659
10 years 148.2
Extreme 148.2
659
Manager TitleAgeSince
Chief Executive Officer 90 19/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 24/10/2025
Director TitleAgeSince
Director/Board Member 48 01/01/2002
Director/Board Member 63 30/09/1993
Chairman 90 01/04/2026
Change 5-day change 1-year change 3-year change Capi.($)
+1.55%+8.06%-18.45%-7.34% 61Cr
+0.43%+6.59%+56.57%+106.64% 1,12000Cr
+0.90%-2.25%+32.26%+63.73% 62TCr
+0.71%+3.24%+24.33%+91.33% 50TCr
-0.13%+5.98%+33.66%+50.18% 37TCr
+0.52%+0.24%+72.13%+40.11% 36TCr
-0.95%+4.70%+19.65%+42.71% 29TCr
-1.98%+3.73%-0.89%+10.43% 26TCr
-0.35%+4.25%+44.74%+52.06% 23TCr
-0.75%+3.32%+27.18%+94.07% 19TCr
Average -0.00%+4.06%+29.12%+54.39% 39.42TCr
Weighted average by Cap. +0.13%+3.83%+39.33%+71.81%

Financials

2025 2026
Net sales 2.11TCr 22Cr 20Cr 18Cr 17Cr 31Cr 32Cr 219.98Cr 86Cr 1.1TCr 83Cr 82Cr 3.51TCr 2.17TCr 23Cr 20Cr 19Cr 17Cr 32Cr 33Cr 226.53Cr 89Cr 1.13TCr 86Cr 84Cr 3.61TCr
Net income 266.79Cr 2.81Cr 2.5Cr 2.32Cr 2.11Cr 3.98Cr 4.04Cr 28Cr 11Cr 139.22Cr 11Cr 10Cr 443.82Cr 281.42Cr 2.97Cr 2.64Cr 2.44Cr 2.22Cr 4.19Cr 4.26Cr 29Cr 12Cr 146.86Cr 11Cr 11Cr 468.16Cr
Net Debt -514.96Cr -5.43Cr -4.82Cr -4.47Cr -4.07Cr -7.68Cr -7.8Cr -54Cr -21Cr -268.72Cr -20Cr -20Cr -856.65Cr -506.04Cr -5.33Cr -4.74Cr -4.39Cr -4Cr -7.54Cr -7.66Cr -53Cr -21Cr -264.07Cr -20Cr -20Cr -841.82Cr
Projected Income Statement - Annual - FDC Limited
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
7,076
Date Price Change Volume
16/26/16 ₹356.70 +1.55% 15,077
15/26/15 ₹351.25 +0.59% 9,976
14/26/14 ₹349.20 +3.31% 2,878
13/26/13 ₹338.00 -1.16% 3,105
12/26/12 ₹341.95 +3.59% 2,684
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B